跳至主要内容
临床试验/NCT06369740
NCT06369740已完成不适用

Case and Use Scenario Study to Gain Knowledge on the User Needs for a Medical Device for Hemophilia a Monitoring

Enzyre B.V.1 个研究点 分布在 1 个国家目标入组 74 人开始时间: 2024年8月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
74
试验地点
1
主要终点
Potential case scenarios for a point of care in-vitro diagnostic device for hemophilia A

研究概览

简要总结

This observational study consists of two parts.

In part one, case scenario focus groups with hemophilia A patients and healthcare providers (HCPs) will be held. This parts aims to identify potential use scenarios of a point of care (POC) in vitro medical for patients with hemophilia A. The main questions it aims to answer are:

  • How is coagulation lab testing for patients with hemophilia A currently organized?
  • What is the interest and what are desired alternatives of a POC in-vitro diagnostic medical device for patients with hemophilia A?

Part two of the study consists of a use scenario study in which patients with hemophilia A and HCPs will evaluate two types of non-functional mock-ups of a POC in vitro medical device. The main goal of this part is to evaluate the usability of the current prototypes of the POC device.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • With Hemophilia A diagnosis
  • All Hemophilia A severity categories are eligible (mild, moderate, or severe)
  • Aged 12 years and older
  • For children aged 12 through 17 their parent must provide permission by signing the informed consent form
  • Consider English their primary language (capable of communicating in English verbally and in writing)
  • Capable of giving informed consent or assent
  • Family member(s) of patients:
  • Related to a patient with Hemophilia A (mild, moderate, or severe)
  • Aged 18 years and older
  • Consider English their primary language (capable of communicating in English verbally and in writing)
  • Capable of giving informed consent or assent
  • Healthcare professionals:
  • Healthcare workers specialized in hemophilia care. (e.g. hematologists, nurse practitioners, physician assistants, nurses, and pharmacists)
  • Capable of giving informed consent

排除标准

  • Without a diagnosis of Hemophilia A
  • With acquired Hemophilia A
  • Younger than 12 years of age
  • Unable to communicate in English
  • Incapable of giving consent or assent for themselves
  • Specifically for the case scenario focus group
  • Unwilling to consent to voice recording
  • Participating in the use scenario part of the study
  • Specifically for the use scenario part of the study
  • Unwilling to consent to video recording
  • Participating in the case scenario part of the study
  • Family members:
  • No relation to a patient with Hemophilia A (mild, moderate, or severe)
  • Related to a patient with acquired Hemophilia A
  • Younger than 18 years of age
  • Unable to communicate in English
  • Incapable of giving consent or assent for themselves
  • Specifically for the case scenario focus group
  • Unwilling to consent to voice recording
  • Participating in the use scenario part of the study
  • Specifically for the use scenario part of the study
  • Unwilling to consent to video recording
  • Participating in the case scenario part of the study
  • Healthcare professionals:
  • Without any prior hematological experience
  • Not licensed as hematologists, nurse practitioners, physician assistants, nurses or pharmacists
  • Unable to communicate in English
  • Incapable of giving their consent to participate
  • Specifically for the case scenario part of the study • Unwilling to consent to voice recording
  • Specifically for the use scenario part of the study
  • Unwilling to consent to video recording

结局指标

主要结局

Potential case scenarios for a point of care in-vitro diagnostic device for hemophilia A

时间窗: One day

Usability issues of the current POC in-vitro diagnostic device prototypes

时间窗: one day

Overview of identified usability issues

Current management of Hemophilia A coagulation lab testing

时间窗: One day

Themes regarding the current management of Hemophilia A coagulation lab testing

次要结局

  • Potential benefits of a POC device for home use, near-patient use or in clinic use(One day)
  • Problems with current Hemophilia A coagulation monitoring(One day)
  • User preferences for the point of care in-vitro diagnostic device(One day)

研究者

发起方
Enzyre B.V.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验